Kidney Int. 2026 Nov 18. pii: S0085-2538(26)00942-7. [Epub ahead of print]
Tanja Eberhart,
Lidia Madrigal Orriols,
Vanessa Suter,
Francesc Castro-Giner,
Christophe D Chabbert,
Jianwen Zhou,
Nicola Zamboni,
Jiong Hu,
Harald C Köfeler,
Nicola Aceto,
Werner J Kovacs.
INTRODUCTION: Clear cell renal cell carcinoma (ccRCC), the most common subtype of RCC, is characterized by constitutive activation of hypoxia-inducible factors (HIF-1α and HIF-2α), with HIF-2α promoting peroxisome turnover. Although peroxisomes play key roles in lipid metabolism and reactive oxygen species homeostasis, they remain relatively understudied in cancer research, and their contribution to ccRCC is poorly understood. Notably, peroxisome abundance is more frequently reduced in low-grade than in high-grade tumors, suggesting a potential role in tumorigenesis.
METHODS: Peroxisome depletion was induced by impairing peroxisome biogenesis and by inducing pexophagy. Tumor growth was evaluated in subcutaneous xenograft models. Multi-omics analyses, including transcriptomics, proteomics, metabolomics, and lipid profiling, were performed on tumor tissues. Cellular metabolism was assessed using Seahorse extracellular flux analysis in spheroids cultured in human plasma-like medium. Changes in the tumor microenvironment (TME) were evaluated by histological analysis.
RESULTS: Peroxisome depletion significantly suppressed ccRCC progression by reducing tumor cell proliferation. It impaired mitochondrial fitness, particularly oxidative phosphorylation, the tricarboxylic acid cycle, and mitochondrial translation. These changes were accompanied by reductions in both glycolytic and mitochondrial flux, resulting in decreased metabolic flexibility and a shift toward a quiescent bioenergetic state that limits tumor growth. Peroxisome-depleted tumors also exhibited oxylipin accumulation. Moreover, peroxisome loss reshaped the TME, as evidenced by increased collagen deposition, enhanced stromal cell infiltration, and a shift in fibroblast populations toward SERPINH1-positive (Serpin Family H Member 1) phenotypes. Consistently, low peroxisome abundance was associated with increased fibrosis in human ccRCC samples.
CONCLUSIONS: Peroxisome loss constrains ccRCC progression through coordinated metabolic and microenvironmental alterations. These findings highlight a previously underappreciated role of peroxisomes in regulating metabolic fitness and the TME in ccRCC, and suggest potential therapeutic strategies aimed at targeting peroxisome homeostasis in kidney malignancies.
Keywords: OXPHOS; ccRCC; fibrosis; mitochondria; oxylipins; pexophagy